Does the duration of postmenopausal osteoporosis affect quality of life and satisfaction?
Bogumiła Górczewska1, Elżbieta Jakubowska-Pietkiewicz1
1Department of Paediatrics, Neonatal Pathology and Metabolic Bone Diseases, Maria Konopnicka University Center for Pediatrics, Lodz, Poland.
Introduction:
Osteoporosis (OP) is a chronic disease that affects all spheres of the patient's life. If it is diagnosed, lifelong treatment is required. The rational mental state of patients is necessary for the proper treatment of the disease. The aim of our study was to assess quality of life and satisfaction of women with postmenopausal osteoporosis depending on the duration of the disease.
Material And Methods:
In the period from June 2018 to May 2019, the women were examined in two osteoporosis treatment clinics in Lodz. The study was conducted among 198 women aged over 50 years with postmenopausal osteoporosis. For this purpose, the Satisfaction with Life Scale (SWLS), QUALEFFO-41 and a self-authored questionnaire were used.
Results:
The mean age of the respondents was 72.3 ±8.59 years (range: 51-90 years), the mean body mass index (BMI) was 25.71 ±4.73 kg/m2. The surveyed women assessed their quality of life as moderate and obtained, according to the QUALEFFO-41 scale, an average score of 40.26 ±16.92 points. The mean result of the level of satisfaction with life, assessed on the SWLS scale, was 19.37 ±7.31 points, which proves moderate satisfaction with life. By comparing the mean SWLS results depending on the duration of the disease, it was shown that the lowest level of life satisfaction was observed in women who had suffered from osteoporosis from 6 to 10 years. The quality of life deteriorated in women with a longer duration of the disease (p = 0.1213). Age, education and marital status had a statistically significant impact on the quality of life.
Conclusions:
The quality of life significantly worsens with the duration of osteoporosis in the respondents. In the study group, we showed moderate satisfaction with life among the subjects. These results emphasize the need to introduce psychological care and educational programs that would focus on women aged over 50 years.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Menopause
Bone Remodeling
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...


